Outlook Therapeutics Announces $55 Million Public Offering of Shares and Warrants

Laura Testa North America Legal Chronicle
Tagged:

Cooley has advised Outlook Therapeutics. Paul Hastings has advised Piper Sandler, BTIG and Brookline Capital Markets as underwriters. Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here